MTS™ (MIC Test Strip)
Support center - Technical sheets
MTS™ Package Insert - IFU
| e-IFU latest version | rev.2 - 19/04/2022 |
Introductory: |
|
|---|---|
| MTS™ Interpretative Criteria and Quality Control | rev.34 - 20/07/2023 |
| MTS™ whole range | rev.59 - 23/04/2024 |
| US FDA-cleared MTS™ (valid for users based in the US) | last update 19/04/2022 |
| MTS™ leaflet | rev.59 - 23/04/2024 |
| MTS™ Multi-Language Introduction | rev.35 - 03/01/2020 |
| Non Hazardous Product Statement MIC Test Strip | rev.0 - 15/12/2017 |
| CE declaration of conformity | rev.37.4 - 22/05/2023 |
| MTS30 - Cidal-Static | rev.3 - 08/06/2015 |
Individual drug technical sheet: |
|
|---|---|
| MTS39 - Ceftobiprole | rev.1 - 24/08/2015 |
| MTS40 - Isavuconazole | rev.0 - 30/10/2015 |
| MTS44 - Solithromycin | rev.0 - 15/12/2016 |
| MTS45 - Fosfomycin | rev.1 - 09/11/2017 |
| MTS47 - Cefepime | rev.1 - 20/12/2018 |
| MTS49 - Piperacillin-tazobactam for Enterobacterales, Pseudomonas, Acinetobacter | rev.1 - 23/12/2022 |
| MTS50 - Piperacillin-tazobactam for Haemophilus, Anaerobes | rev.0 - 17/06/2020 |
| MTS51 - Cefiderocol | rev.0 - 03/05/2021 |
| MTS52 - Aztreonam-avibactam | rev.0 - 05/10/2022 |
| MTS53 - Rezafungin | rev.0 - 29/11/2023 |
Resistance mechanisms detection: |
|
|---|---|
| MTS26 - ESBL | rev.2.1 - 07/11/2014 |
| MTS27 - MBL | rev.4 - 04/06/2021 |
| MTS28 - GRD | rev.2.1 - 11/04/2016 |
| MTS29 - AmpC | rev.3 - 01/07/2014 |
| MTS35 - KPC | rev.4 - 07/08/2015 |